CYP2C9 and hereditary antithrombin deficiency: This case illustrates an extremely rare instance of dual anticoagulant resistance profound challenges in achieving therapeutic anticoagulation with two standard agents, highlighting the need for a structured diagnostic algorithm including compliance verification, pharmacokinetic and pharmacodynamic assessment, consideration of genetic testing (VKORC1, CYP2C9), and evaluation for antithrombin deficiency.